Status:
COMPLETED
Impact of the COVID-19 Pandemic in Gynecological Oncology
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Gynecologic Cancer
Breast Neoplasm Female
Eligibility:
FEMALE
18+ years
Brief Summary
The current infection with the Coronavirus SARS-CoV-2 (COVID-19) is an exceptional health situation which requires an adaptation of our management practices in gynecological oncology. Data from the li...
Eligibility Criteria
Inclusion
- women over 18
- gynecological cancer (breast cancer, uterus, ovary, cervix, vagina or vulva cancer)
- therapeutic management planned during quarantine
- person having expressed his non-opposition
- Inclusion Criteria of control group :
- women over 18
- gynecological cancer (breast, uterus, ovary, cervix, vagina or vulva cancer)
- therapeutic management planned on the end of the year 2019
- person having expressed his non-opposition
Exclusion
- inability to understand the information given
- person deprived of liberty,
- person under guardianship.
Key Trial Info
Start Date :
May 6 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
205 Patients enrolled
Trial Details
Trial ID
NCT04351139
Start Date
May 6 2020
End Date
November 30 2020
Last Update
January 19 2021
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Gynécologie, HFME, Hospices Civils de Lyon
Bron, France, 69500
2
Service de Gynécologie, Croix-Rousse, Hospices Civils de Lyon
Lyon, France, 69004
3
Service Gynécologie, CHLS, Hospices Civils de Lyon
Pierre-Bénite, France, 69310